![](/fileadmin/_processed_/csm_BEPO_tech_e886e364e0.png)
Unitaid awards Medincell US$6m to fight malaria
The funding commitment for MedinCell Corp’es reformulation of the antipararsitic ivermectin comes after great progress in malaria vaccines: The...
![](/fileadmin/_processed_/csm_Fundus_-_diabetic_retinopathy_c83d88301e.png)
MSD grabs Eyebiotech Ltd for US$1.3bn upfront
With the strategic acquisition,which has been unanimously approved by the EyeBio Board of Directors, MSD will take over Eyebiotech's clinical...
![](/fileadmin/_processed_/csm_Neuroblastom_Primary_super_close_merged_cfdf8283a7_47aac544fd.jpg)
Essential Pharma acquires Renaissance Pharma Ltd
Renaissance Pharma Ltd, which was only founded in September 2023 with the licensing of the anti-GD2 antibody from St Jude Children's Research...
![](/fileadmin/_processed_/csm_Adrenomed_cf30735df8.png)
Shock: Adrenomed AG gets FDA fast track designation
After Adrenomed AG has demonstrated that its septic shock treatment led to a 60% reduction in relative 28-day mortality vs. placebo in a stratified...
![](/fileadmin/_processed_/csm_Fundus_of_patient_with_retinitis_pigmentosa__mid_stage_10790b28cb.jpg)
Three companies launch gene therapy alliance for eye diseases
Today, the companies officially announced the launch of the GEAR partnership (Evaluation of Adeno-Associated Virus Vector Gene Therapy for the...
![](/fileadmin/_processed_/csm_New-Expansion-Site-Rendering-in-Clayton-1_f5772ed7b0.jpg)
Novo Nordisk expands footprint in USA
Novo Nordisk realises a major expansion in Clayton, NC. The project will enhance Novo Nordisk's manufacturing capabilities with more than 1.4...
![](/fileadmin/Content/NewsAndStories/2024/Bildschirmfoto_2024-07-09_um_09.31.12.png)
EMA-Gate: PharmaMar wins suit against EMA
The European Commission has corrected its decision C(2018) 4831 from 2018 not to grant marketing authorisation for Aplidin (plitidepsin), a peptidic...